Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02466685 |
|
Recruitment Status :
Active, not recruiting
First Posted : June 9, 2015
Last Update Posted : January 19, 2022
|
Sponsor:
Herbert Meltzer
Collaborator:
Janssen Research & Development, LLC
Information provided by (Responsible Party):
Herbert Meltzer, Northwestern University
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | September 2021 |
| Estimated Study Completion Date : | December 2022 |
| Submission Cycle | Results Submitted to ClinicalTrials.gov | Results Returned after Quality Control Review |
|---|---|---|
| 1 |
March 21, 2023 |